CXCL13 and neoplasm: Noteworthily, we identify unique cell populations, including CXCL13+ CAFs and CXCL13+CD8+ T cells, among other immune cells commonly reported in multiple cancers, suggesting the feasibility of using NPC as a model to study the heterogenous TLS in tumours.